Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Pneumothorax-I

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey.

JHEP reports : innovation in hepatology·2026

Same author

Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort.

JHEP reports : innovation in hepatology·2026

Same author

Impact of an educational video on the quality of bowel preparation prior to colonoscopy: a randomized controlled study.

Clinics and research in hepatology and gastroenterology·2026

Same author

Haemodynamic responses to sotatercept and parenteral prostacyclins in pulmonary arterial hypertension patients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Design of PROGRESSION-IPF: A pragmatic, open-label, randomized trial of patients with progressive disease in idiopathic pulmonary fibrosis.

Respiratory medicine and research·2026

Same author

Prognostic factors in interstitial lung disease-associated pulmonary hypertension: data from the HYPID cohort and the French Pulmonary Hypertension Registry.

The European respiratory journal·2026

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

[Hepatopulmonary syndrome].

Thierry Thévenot¹, Delphine Weil¹, Armand Garioud²

¹Hôpital universitaire Jean-Minjoz, service d'hépatologie et de soins intensifs digestifs, 25030 Besançon, France.

Presse Medicale (Paris, France : 1983)

|March 30, 2016

Summary

This summary is machine-generated.

Hepatopulmonary syndrome (HPS) involves liver disease, dilated lung vessels, and low oxygen. Liver transplantation offers the best hope for resolving HPS and improving survival.

More Related Videos

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Published on: November 29, 2018

Related Experiment Videos

Last Updated: Mar 23, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure

Published on: November 29, 2018

Area of Science:

Cardiology
Pulmonology
Gastroenterology

Background:

Hepatopulmonary syndrome (HPS) is a serious complication of liver disease.
It is characterized by portal hypertension, widened alveolar-arterial oxygen gradient, and intrapulmonary vascular dilations.
Key pathophysiological mechanisms include ventilation-perfusion mismatch, diffusion limitation, and right-to-left shunting, driven by factors like nitric oxide and VEGF.

Purpose of the Study:

To define the key features and mechanisms of hepatopulmonary syndrome.
To discuss the diagnostic challenges and limitations of screening tests like pulse oximetry.
To evaluate the efficacy of current treatments, particularly liver transplantation.

Main Methods:

Review of existing literature on hepatopulmonary syndrome.
Analysis of pathophysiological mechanisms contributing to hypoxemia in HPS.
Assessment of clinical presentation, diagnostic tools, and treatment outcomes.

Main Results:

HPS presents with non-specific symptoms, primarily progressive dyspnea.
Pulse oximetry can screen for severe HPS but has limitations.
Medical treatments for HPS are generally disappointing.

Conclusions:

Liver transplantation is the only treatment that can resolve hepatopulmonary syndrome.
Survival rates after liver transplantation are encouraging, especially in patients with less severe hypoxemia.